Charles River Laboratories | GJELD



Debt Endring Dato
Agilent USD 3.36B 27M 2025-01
Align Technology USD 0 0 2024-12
Bio-Rad Laboratories USD 1.2B 276K 2024-12
Bruker USD 2.09B 203M 2024-12
Cardinal Health USD 7.61B 2.44B 2024-12
Charles River Laboratories USD 2.24B 86.72M 2024-12
Cigna USD 31.97B 830M 2024-12
CVS Health USD 66.27B 736M 2024-12
Danaher USD 16.01B 1.52B 2024-12
Dentsply International USD 2.14B 82M 2024-12
Elevance Health USD 31.23B 4.08B 2024-12
Galapagos EUR 11.72M 257K 2024-12
Hologic USD 2.54B 9.7M 2024-12
Humana USD 11.72B 1.3B 2024-12
Illumina USD 1.99B 1000K 2024-12
Incyte USD 37.96M 5.81M 2024-12
IQVIA Holdings USD 13.98B 471M 2024-12
Laboratory Of America USD 6.41B 421.6M 2024-12
Lonza CHF 4.71B 915M 2024-12
McKesson USD 8.01B 2.27B 2024-12
Merck EUR 11.38B 636M 2024-09
Mettler Toledo International USD 2.01B 63.6M 2024-12
Novartis USD 31.26B 828M 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Quest Diagnostics USD 6.22B 753M 2024-12
Revvity USD 3.15B 36.03M 2024-12
Thermo Fisher Scientific USD 31.28B 4.04B 2024-12
United Therapeutics USD 300M 100M 2024-12
UnitedHealth USD 76.9B 1.11B 2024-12
Walgreens Boots Alliance USD 9.06B 1.48B 2024-11
Waters USD 1.63B 199.76M 2024-12
West Pharmaceutical Services USD 205.6M 100K 2024-12



Charles River Laboratories GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.